Opening Up to Precompetitive Collaboration

The move to increase biomedical R&D efficiency and innovation has stimulated the development of collaborations, among competitors, that span the precompetitive space. In order to enhance biomedical research and development efficiency and innovation, nontraditional research collaborations have emerged that feature the sharing of information, resources, and capabilities. Although many of these so-called precompetitive collaborations are in the field of oncology, the lessons they offer are broadly applicable to other subfields of translational medicine.

[1]  N. Cohen,et al.  Open innovation networks between academia and industry: an imperative for breakthrough therapies , 2009, Nature Medicine.

[2]  B. Munos.  Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.

[3]  Andrej Sali,et al.  Finding Cures for Tropical Diseases: Is Open Source an Answer? , 2004, PLoS medicine.

[4]  J. De,et al.  Will disruptive innovations cure health care , 2000 .

[5]  L. Proenza,et al.  University-Private Sector Research Partnerships in the Innovation Ecosystem , 2008 .

[6]  Sujoy Ghosh,et al.  The Biomarkers Consortium: Practice and Pitfalls of Open‐Source Precompetitive Collaboration , 2010, Clinical pharmacology and therapeutics.

[7]  Lee Harland,et al.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery , 2009, Nature Reviews Drug Discovery.

[8]  J. Travis.  Prizes Eyed to Spur Medical Innovation , 2008, Science.

[9]  E Ray Dorsey,et al.  Funding of US biomedical research, 2003-2008. , 2010, JAMA.

[10]  D. Berry,et al.  I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy , 2009, Clinical pharmacology and therapeutics.

[11]  Asphalt Pavement Mixes.  DEVELOPMENT OF A , 2011 .

[12]  C. Nathan.  Aligning pharmaceutical innovation with medical need , 2007, Nature Medicine.

[13]  John Travis.  Science by the Masses , 2008, Science.

[14]  Bernard H. Munos,et al.  Can open-source R&D reinvigorate drug research? , 2006, Nature Reviews Drug Discovery.

[15]  Jason I Reminick,et al.  Funding of US Biomedical Research , 2011 .

[16]  Arti K. Rai,et al.  Open and Collaborative Research: A New Model for Biomedicine , 2004 .

[17]  B. Munos,et al.  A Call for Sharing: Adapting Pharmaceutical Research to New Realities , 2009, Science Translational Medicine.

[18]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[19]  G. Brown,et al.  Will disruptive innovations cure health care? , 2001, Harvard business review.